Study for Cerebral Palsy Using Siddha Medicine

Phase II Non Randomized Clinical Study In The Management Of Sirakambavatham (Cerebral Palsy) With The Validation Of Siddha Trial Drug Sirakambavathathirkku Kudineer As Internal Medicine And Saranai Thailam As External Therapy - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/069667

Enrollment

Registered

2024-06-28

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system

Interventions

Intervention1: Sirakambavathathirkku Kudineer (Internal medicine) and Saranai Thailam (external therapy): Sirakambavathathirkku Kudineer (Internal medicine) 5-10 ml twice a day for 60 days and Sarana

Eligibility

Inclusion criteria

Inclusion criteria: Delay in gross motor and fine motor milestones Delay in intellectual and cognitive functional development Abnormal muscle tone and reflexes spastic cerebral palsy

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
It is mainly assessed by reduction in clinical symptomsTimepoint: 60 days	—

Secondary

Measure	Time frame
It is assessed by comparing the sensory functions connecting parameters and fine motor functions of the upper limbTimepoint: 60 days	—

Countries

India

Contacts

Public ContactDr N Manju Hemamalini

Government Siddha Medical College Arumbakkam Chennai 106

mahema.siddha@gmail.com9894325360

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026